Next-Generation Sequencing (NGS) denotes high-throughput sequencing in a massively parallel fashion that brought a huge impact at far lower cost using a variety of novel platform technologies. With its ultra-high throughput, scalability, and speed, NGS enables many applications that require sequences of DNA and/or RNA. The applications include whole-genome sequencing (WGS) of organisms that have multiple, large chromosomes requiring sophisticated algorithms for sequence assembly, analysis of temporal and spatial patterns of RNA expression, annotation of novel genomes and their encoded genes using bioinformatic tools, studies on the epigenetic changes in genomes, and analyses of single nucleotide polymorphisms and genetic signatures that either predict genetic disease susceptibility or the presence of desirable genetic traits. NGS also provides deep insights into the biological diversity and evolutionary history of populations, whether they are of viral, microbial, plant, or human origin.
Related Posts
Health expert calls for reducing booster dose gap from 9 to 6 months
Director of Tata Institute for Genetics and Society (TIGS), Bengaluru, Dr Rakesh... read more
Rare Disease Day 2025
✨On 28th February i.e. Rare Disease Day 2025 , TIGS and NCBS... read more
2025 SAGE program ambassadors visit to TIGS
✨We were delighted to host the senior and junior ambassadors of the... read more
TIGS participation in Racefor7 2023
Racefor7 is an annual event organised by the Organization for Rare Diseases... read more
OneHealth national agenda meeting
A meeting at Indian Institute for Science (IISc), involving various academic, research... read more
Sewage monitoring may hold key to handling future pandemics
'Sewage surveillance would help in public health responses and preventive care like... read more
‘Not Done With Covid Pandemic Yet’: Experts Say Future Depends On New Variants, Need to be Watchful
“We should still wait to call the Covid pandemic has reached its... read more
India must scale up wastewater analysis for health surveillance
In this latest opinion piece by Dr. Farah Ishtiaq, Principal Scientist, TIGS... read more
Talk by Dr. Rakesh Mishra at Rare Diseases Summit 2023
Dr Rakesh Mishra, Director, Tata Institute for Genetics and Society, was invited... read more
Delegation visit from Swissnex in India
We were pleased to host a delegation from Swissnex in India to... read more